Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues-Reference-Cited by-同舟云学术

Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues

Published:2019-09-29 Issue:1 Volume:21 Page:95-100
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Li Alex M.¹^ORCID,Boichard Amélie²^ORCID,Kurzrock Razelle²^ORCID

Affiliation:

1. University of California San Diego School of Medicine, La Jolla, CA, USA

2. Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2019.1665956

Reference27 articles.

1. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

2. Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

3. Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study

4. The US FDAs withdrawal of the breast cancer indication for Avastin (bevacizumab)

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Precision guided reactive cancer management: molecular complete response in heavily pretreated metastatic CRC by dual immunotherapy and sorafenib;FRONT ONCOL;2024

2. Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors;Journal of Cancer Research and Clinical Oncology;2024-04-30

3. Network targeting combination therapy of synthetic lethal vulnerabilities in 9p21-deficient glioblastoma: A case report;Neuro-Oncology Advances;2023-12-10

4. Regulation of Vascular Endothelial Growth Factor Signaling by Nicotine in a Manner Dependent on Acetylcholine-and/or β-Adrenergic-Receptors in Human Lung Cancer Cells;Cancers;2023-11-21

5. Case Report: A novel TP53 mutation in a patient with quadruple wild-type gastrointestinal stromal tumor;Frontiers in Oncology;2023-11-09